Manxiang Li
Impact in
-
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
- Cardiac Fibrosis and Remodeling
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
- Cancer Research top 5%
Papers in
-
- Cancer-related molecular mechanisms research 14
-
- Pulmonary Hypertension Research and Treatments 36
- Chronic Obstructive Pulmonary Disease (COPD) Research 20
- Respiratory Support and Mechanisms 7
- Co-authors
- Yibin WangDavid A. KassHunter C. ChampionEiki TakimotoKathleen L. GabrielsonShuxun RenE. René RodríguezYanting Zhu
- Journals
- European Journal of Pharmacology (7 papers)Life Sciences (7 papers)Journal of Cancer (4 papers)Experimental Lung Research (3 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Manxiang Li
137 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cardiology and Cardiovascular Medicine 1.3k
- Cancer Research 500
- Molecular Biology 2.2k
- Pulmonary and Respiratory Medicine 1.0k
- Physiology 747
Countries citing papers authored by Manxiang Li
This map shows the geographic impact of Manxiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manxiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manxiang Li more than expected).
Fields of papers citing papers by Manxiang Li
This network shows the impact of papers produced by Manxiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manxiang Li. The network helps show where Manxiang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Manxiang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 15 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 21 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 25 | |
| 9 | 2019 | 15 | |
| 10 | 2018 | 19 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 63 | |
| 13 | 2017 | 17 | |
| 14 | 2016 | 28 | |
| 15 | 2014 | 48 | |
| 16 | 2014 | 17 | |
| 17 | 2013 | 25 | |
| 18 | 2012 | 1 | |
| 19 | 2005 | 373 | |
| 20 | 2002 | 288 |
About Manxiang Li
Manxiang Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Biochemistry and Physiology, having authored 140 papers that have together received 4.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (36 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Asthma and respiratory diseases (17 papers), Cancer-related molecular mechanisms research (14 papers), PI3K/AKT/mTOR signaling in cancer (13 papers), Circular RNAs in diseases (10 papers), Metabolism, Diabetes, and Cancer (9 papers) and Respiratory Support and Mechanisms (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Cancer Research (500 citations), Molecular Biology (2.2k citations), Pulmonary and Respiratory Medicine (1.0k citations) and Physiology (747 citations). Manxiang Li has collaborated with scholars based in China, United States and India. Frequent co-authors include Yibin Wang, David A. Kass, Hunter C. Champion, Eiki Takimoto, Kathleen L. Gabrielson, Shuxun Ren, E. René Rodríguez, Yanting Zhu, Shaojun Li and Diego Belardi. Their work appears in journals such as European Journal of Pharmacology, Life Sciences, Journal of Cancer, Experimental Lung Research and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.